Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGENOMICS INC Director's Dealing 2016

Jan 28, 2016

32227_dirs_2016-01-28_abdacc97-a4a9-4bba-a4d6-2d719768ad3b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2015-12-31

Reporting Person: CROWTHER BRUCE K (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-05-06 Stock Option (Right to Buy) $4.78 A 10000 Acquired 2020-05-06 Common Stock (10000) Direct

Footnotes

F1: On May 6, 2015 Mr. Crowther was granted 10,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.